You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2022
|
| DOI | 10.1136/jitc-2022-005755 |
| Pubmed ID | |
| Authors |
Jason Chesney, Karl D Lewis, Harriet Kluger, Omid Hamid, Eric Whitman, Sajeve Thomas, Martin Wermke, Mike Cusnir, Evidio Domingo-Musibay, Giao Q Phan, John M Kirkwood, Jessica C Hassel, Marlana Orloff, James Larkin, Jeffrey Weber, Andrew J S Furness, Nikhil I Khushalani, Theresa Medina, Michael E Egger, Friedrich Graf Finckenstein, Madan Jagasia, Parameswaran Hari, Giri Sulur, Wen Shi, Xiao Wu, Amod Sarnaik |
X Demographics
The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 15 | 43% |
| Spain | 3 | 9% |
| United Kingdom | 2 | 6% |
| India | 1 | 3% |
| Unknown | 14 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 51% |
| Scientists | 8 | 23% |
| Practitioners (doctors, other healthcare professionals) | 7 | 20% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 66 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 7 | 11% |
| Other | 6 | 9% |
| Unspecified | 6 | 9% |
| Researcher | 6 | 9% |
| Student > Bachelor | 5 | 8% |
| Other | 3 | 5% |
| Unknown | 33 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 14% |
| Unspecified | 6 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 8% |
| Immunology and Microbiology | 5 | 8% |
| Agricultural and Biological Sciences | 3 | 5% |
| Other | 4 | 6% |
| Unknown | 34 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 225. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2024.
All research outputs
#173,633
of 25,779,988 outputs
Outputs from Journal for Immunotherapy of Cancer
#35
of 3,513 outputs
Outputs of similar age
#4,721
of 485,128 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 121 outputs
Altmetric has tracked 25,779,988 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,513 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 485,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.